Cangrelor

Cardiology

Cardiology · IV reversible P2Y12 (t½ 3–6 min)

Cangrelor

Dose

30 mcg/kg bolus + 4 mcg/kg/min infusion during PCI.

Indications

  • PCI when oral P2Y12 not feasible

Use

Bridge to oral P2Y12 in periprocedural setting.

Monitoring

Bleeding.

Side effects

  • Bleeding
  • Dyspnoea

Always confirm dose against your local formulary / BNF before prescribing.

WardRound

WardRound

Clinical Decisions in Seconds